RT @Eurosurveillanc: @ECDC_EU @ECDC_Outbreaks @ZI_Atlas @a_husby @TyraGroveKrause Sensitivity analyses found that living in a household with young children slightly increased the risk of #SARSCoV2 infection (adjusted hazard ratio 1.10 (95% CI: 1.08–1.12) but not hospitalisation
👇
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.32.2101096
RT @VaccinesToday: 45 of 53 @WHO_Europe countries are now ‘rubella free’.
Despite pandemic-related disruption of immunisation services, the defeat of a devastating disease is in sight.
https://t.co/o4SGSHIU8B @WHO_Europe_VPI @ECDC_EU @ECDC_VPD #vaccineswork #rubella
Ready for another #ECDConAir podcast episode?
This time we sat down with #ECDC's expert Svetla Tsolova to talk about #CommunityPreparedness.
Give it a listen on:
@anchor ⚓️ - https://bit.ly/3AjK8AT
@YouTube ▶️ - https://youtu.be/tm01q3gsl38
@Spotify 🎧 - https://spoti.fi/3QCMgJu
RT @ECDC_Outbreaks: This week's communicable disease threats report covers:
-> #WestNile virus infection,
-> #COVID19
-> #monkeypox
-> #measles
-> Crimean-Congo haemorrhagic fever,
-> #Langya #henipavirus
-> #dengue, mass gatherings, #Vibrio growth, #SwineInfluenza & #polio.
https://www.ecdc.europa.eu/en/publications-data/communicable-disease-threats-report-7-13-august-2022-week-32
RT @ECDC_Outbreaks: #JustPublished!
#Langya #henipavirus under ECDC monitoring.
According to a group of Chinese scientists, the detection of a previously unknown, phylogenetically distinct henipavirus, named Langya henipavirus (#LayV), was reported in China.
https://www.ecdc.europa.eu/en/news-events/langya-henipavirus-under-ecdc-monitoring
#Langyavirus
RT @Eurosurveillanc: @ECDC_EU @ECDC_Outbreaks @ZI_Atlas Research article
#SARSCoV2 infection in households with and without young children: Nationwide cohort study, Denmark, 27 February 2020 to 26 February 2021
👉 https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.32.2101096
@a_husby @TyraGroveKrause
RT @Eurosurveillanc: A new 𝘌𝘶𝘳𝘰𝘴𝘶𝘳𝘷𝘦𝘪𝘭𝘭𝘢𝘯𝘤𝘦 issue is out
#SARSCoV2 #COVID19 #Lyme #Borreliosis #MonkeypoxVirus #MPX #PCR #publichealth
#ESCAIDE2022 registration is now open!
Meet with other #epi specialists in Stockholm or online!
Read more about the registration here: https://www.escaide.eu/en/registration
and don't forget to look at the programme:
https://www.escaide.eu/en/escaide-programme-2022
Hope to see YOU there!
#ESCAIDE
RT @ESCAIDE: The registration for the hybrid #ESCAIDE2022 is now open!
Want to participate in person?
Apply till 5 September! Be quick, a…
Latest joint #ECDC-@WHO_Europe #monkeypox surveillance report is now online!
Read more here:
https://monkeypoxreport.ecdc.europa.eu/
Or in the #mpx thread below ⬇️⬇️⬇️
RT @ECDC_Outbreaks: #UPDATE!
Joint #ECDC-@WHO_Europe #monkeypox surveillance bulletin.
Up to August 9, 17509 #mpx cases from 35 EU/EEA/Europe Region countries and areas were reported through #TESSy.
The majority of cases were 31-40 years-old (40%) and male (99%).
h…
RT @tephinet: This #WorldFieldEpidemiologyDay, we pay tribute to field epidemiologists fighting against health emergencies.
@mohgovgh Biomedical Scientist Frank Osei Asare shares how empowering field epidemiologists enables more immediate control of #outbreaks & prevents future epidemics.
RT @_katusche: Some 🆕WHO updates on #monkeypox:
@WHO global sitrep 👉 https://www.who.int/publications/m/item/multi-country-outbreak-of-monkeypox--external-situation-report--3---10-august-2022
@WHO global summary 👉https://worldhealthorg.shinyapps.io/mpx_global/
@WHO_Europe & @ECDC_EU updating our regional case-based data👉 https://monkeypoxreport.ecdc.europa.eu/
RT @SKyriakidesEU: Important discussion with @EU_Health, @EMA_News, @ECDC_EU, #HERA on 🇪🇺 response to #Monkeypox.
As well as procuring vaccines and therapeutics we are providing vital support to Member States on surveillance, data reporting, vaccination strategies and information for our citizens.
RT @Eurosurveillanc: @ECDC_EU @ECDC_Outbreaks @CIBER_ESP @WHO_Europe @Folkhalsomynd 427 cases with paediatric #hepatitis of unknown origin were analysed
Of reported cases
➡️ 77.3% were under 5
➡️ 53.5% tested positive for adenovirus
➡️ 10.4% tested positive for #SARSCov2
➡️ 10.3% were coinfected with both pathogens
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.31.2200483
Want to know more about #epidemiology?
Give our #ECDConAir podcast a listen!
There are already 23 episodes about a wide range of #epi topics waiting for you!
Available on:
YouTube: https://bit.ly/ECDConAirYT
Anchor: https://anchor.fm/ecdc
Spotify: https://spoti.fi/3vQa2tn
& more!
RT @EU_Health: The COVID-19 pandemic highlighted gaps in our global health security architecture
As we craft our 🆕#EUGlobalHealthStrategy, we invite you to share your views on:
▶️Pandemic preparedness & response
▶️Strong & sustainable healthcare systems
#EUHaveYourSay until 19 September
RT @SKyriakidesEU: Today’s agreement with Moderna will support 🇪🇺 preparedness against #COVID19 in autumn and winter.
Member States will have access to vaccines for citizens at the right time, including those adapted to variants, as and when authorised by @EMA_News.
https://ec.europa.eu/commission/presscorner/detail/en/ip_22_4843
RT @ECDC_Outbreaks: A weekly sum up of the #epidemiology monitoring. Our latest #CDTR issue covers:
#WestNile virus infection,
#monkeypox
#COVID19
#cholera
#diphteria
#anthrax
#Vibrio growth
#Marburg virus disease
mass gatherings
#MERSCoV and #Poliovirus.
RT @WHO: Here's what you need to know if you are recovering from #monkeypox at home 👇
@noawitheringly Thank you @noawitheringly! :)
RT @Eurosurveillanc: @ECDC_EU @ECDC_Outbreaks @CIBER_ESP @WHO_Europe Rapid communication
Functional immunity against #SARSCoV2 in the general population after a booster campaign and the Delta and Omicron waves, 🇨🇭, March 2022
💉 https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.31.2200561
@PuhanMilo @SerenaSabatini @UZH_en
Unofficial automated mirror. No copyright asserted. ∎ The European Centre for Disease Prevention and Control. We aim to strengthen #Europe's defences against infectious diseases.